We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only
Long-term biochemical and virological response to natural interferon-α in patients with chronic hepatitis C
✍ Scribed by Hideki Hagiwara; Norio Hayashi; Akinori Kasahara; Masahide Oshita; Kazuhiro Katayama; Masafumi Naito; Manabu Masuzawa; Harumasa Yoshihara; Yoji Shimizu; Hideyuki Fusamoto; Takenobu Kamada
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 806 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
CORRESPONDENCE 1287 tive anions determine the potential for crystal precipi-though the location within the stone is not identified. Thus, their data would seem to confirm our findings tation within bile. Certain disease states predispose and be in conflict with the statement in their letter to supe
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986
Hepatitis C virus (HCV) carriers with normal aminotransferase levels often show histological chronic hepatitis. This study was undertaken to determine the effect of interferon (IFN) in such patients. Nineteen HCV carriers with normal aminotransferase activities and chronic hepatitis were randomized